Management Credibility Analysis
Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.
Upcoming Catalysts
Verified event feedVerified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.
Company profile
No description available
- Chief executive
- Not disclosed
- Headquarters
- 9920 PACIFIC HEIGHTS BLVD, SUITE 350, SAN DIEGO, CA
- Founded
- Not disclosed
📈 Company Timeline
Major business events
Positive
Negative
Neutral
28 Sep 2026
Viking Therapeutics, Inc. reported A material agreement
Viking Therapeutics, Inc. filed an 8-K covering a material agreement, a material financing obligation, supporting financial statements or exhibits.
22 Sep 2026
Viking Therapeutics, Inc. reported Another company event
Viking Therapeutics, Inc. filed an 8-K covering another company event, supporting financial statements or exhibits.
29 Jul 2026
Viking Therapeutics, Inc. filed Form 10-Q
Viking Therapeutics, Inc. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
29 Jul 2026
Viking Therapeutics, Inc. reported Operating or financial results
Viking Therapeutics, Inc. filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
26 May 2026
Viking Therapeutics, Inc. reported Shareholder voting results
Viking Therapeutics, Inc. filed an 8-K covering shareholder voting results, supporting financial statements or exhibits.
Capital Structure & Financial Position
Financial strength and liquidity analysisVerified Capital Structure Unavailable
Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.
Peer Comparison - Health Care
| Company | Price | Market Cap |
|---|---|---|
| LLY - Eli Lilly and Company |
$1,276.13
Yahoo Finance |
$1.20T |
| JNJ - Johnson & Johnson |
$256.74
Yahoo Finance |
$618.71B |
| ABBV - AbbVie Inc. |
$284.80
Yahoo Finance |
$503.28B |
| UNH - UnitedHealth Group Incorporated |
$418.43
Yahoo Finance |
$375.58B |
| MRK - Merck & Co., Inc. |
$148.55
Yahoo Finance |
$366.50B |
📋 Corporate Actions
Recent and upcoming corporate eventsVerified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.
Financials
Financial statements and key metrics analysisVerified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.
Analyst Consensus
Analyst Consensus Unavailable
No reliable analyst consensus source returned data for this stock.
💰 Upcoming Dividends
Next dividend paymentsVerified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.
Guidance Evolution
Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.
💼 Director Transactions
Recent insider activityVerified Insider Transactions Unavailable
Director and insider transaction data is not ingested for this stock yet.
Top Shareholders
Verified Shareholders Unavailable
Institutional ownership data is not ingested for this stock yet.